CCR5 and neoplasm: In tumor initiation, circulating Vγ9Vδ2 T cells, activated by the over-produced IPP in cancer cells, express the inflammatory homing chemokine receptors (e.g., CXCR3 and CCR5), guiding them into tumor sites (69, 70).